Clinical Trial: Clinical Study of MK-4884 in Participants With Advanced or Metastatic Solid Tumors (MK-4884-001)

U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT07600749) titled 'Clinical Study of MK-4884 in Participants With Advanced or Metastatic Solid Tumors (MK-4884-001)' on May 15.

Brief Summary: Researchers are looking for new ways to treat certain types of advanced and/or metastatic solid tumors.

The main goal of this study is to learn about the safety of different doses of MK-4884 and if participants tolerate them.

Study Start Date: June 15

Study Type: INTERVENTIONAL

Condition: Malignant Neoplasm

Intervention: DRUG: MK-4884

Oral Administration

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Merck Sharp & Dohme LLC

Published by HT Digital Content Services with permission from Health Daily Di...